2020
DOI: 10.3390/ijms21113864
|View full text |Cite
|
Sign up to set email alerts
|

When Good Guys Turn Bad: Bone Marrow’s and Hematopoietic Stem Cells’ Role in the Pathobiology of Diabetic Complications

Abstract: Diabetes strongly contributes to the development of cardiovascular disease, the leading cause of mortality and morbidity in these patients. It is widely accepted that hyperglycemia impairs hematopoietic stem/progenitor cell (HSPC) mobilization from the bone marrow (BM) by inducing stem cell niche dysfunction. Moreover, a recent study demonstrated that type 2 diabetic patients are characterized by significant depletion of circulating provascular progenitor cells and increased frequency of inflammatory cells. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 183 publications
(213 reference statements)
0
18
0
Order By: Relevance
“…To this regard, a chronic low-grade inflammation and immune activation have been described both in pre-diabetic and diabetic states [ 27 , 28 , 29 , 30 ]. A consisting body of literature suggests that the impact of hyperglycemia on HSPCs in the BM niche may be the primary factor contributing to CV disease development [ 31 , 32 ]. Indeed, numerous preclinical data show the ability of BM diabetic environment to boost HSPC differentiation toward myeloid lineage as well as to promote abnormal generation and accumulation of immune cell subpopulations (e.g., monocytes and macrophages) with more aggressive phenotypes [ 33 , 34 , 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…To this regard, a chronic low-grade inflammation and immune activation have been described both in pre-diabetic and diabetic states [ 27 , 28 , 29 , 30 ]. A consisting body of literature suggests that the impact of hyperglycemia on HSPCs in the BM niche may be the primary factor contributing to CV disease development [ 31 , 32 ]. Indeed, numerous preclinical data show the ability of BM diabetic environment to boost HSPC differentiation toward myeloid lineage as well as to promote abnormal generation and accumulation of immune cell subpopulations (e.g., monocytes and macrophages) with more aggressive phenotypes [ 33 , 34 , 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, delayed fracture healing due to the BMP6 downregulation has been reported in a streptozotocin-induced rat diabetes model ( 43 ). The low Bmp6 expression levels in smooth muscle progenitor cells in a mouse diabetes model ( 44 ) and in myofibroblast progenitor cells of patients with diabetes ( 45 ) has suggested the role of BMP6 in vascular tissue remodeling, which may promote the generation of cells with antiangiogenic and profibrotic properties ( 46 ). The present study aimed to investigate whether exocrine pancreatic damage may impact glucose metabolism in aging Bmp6 −/− mice.…”
Section: Discussionmentioning
confidence: 99%
“…Diabetes leads to numerous abnormalities in the BM, such as small vessel disease (microangiopathy), nerve terminal damage (neuropathy), and impaired stem cell mobilization (mobilopathy) [87]. These pathologic manifestations are elicited by a dramatic shift in the local BM microenvironment, which includes changes to the inflammatory milieu and the cellular components of the niche (reviewed in [88]). Diabetes results in systemic dysfunction of endothelial cells [89], and there is diminished mobilization of endothelial progenitor cells (EPCs) from the BM into the blood in diabetes [90].…”
Section: Diabetes-mediated Changes To the Bone Marrow Nichementioning
confidence: 99%